AnaptysBio, Inc. logo

AnaptysBio, Inc.

NASDAQ:ANAB

Overview | Financials
Company Name AnaptysBio, Inc.
Symbol ANAB
Currency USD
Price 40.33
Market Cap 1,217,957,934
Dividend Yield 0%
52-week-range 13.36 - 41.308
Industry Biotechnology
Sector Healthcare
CEO Mr. Daniel R. Faga
Website https://www.anaptysbio.com

An error occurred while fetching data.

About AnaptysBio, Inc.

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through

Related Stocks

Vaxxinity, Inc. logo

Vaxxinity, Inc.

VAXX

0.08 USD

Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc.

VNDA

5.1 USD

UFP Technologies, Inc. logo

UFP Technologies, Inc.

UFPT

317.79 USD

Quantum-Si incorporated logo

Quantum-Si incorporated

QSI

0.923 USD

Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX

16.76 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

5.64 USD

Aveanna Healthcare Holdings Inc. logo

Aveanna Healthcare Holdings Inc.

AVAH

5.39 USD

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLL

37.5 USD

Financials

Numbers are in millions USD

Numbers are in millions USD